Abstract:Deposition and aggregation of β-amyloid (Aβ) peptides are demonstrated to be closely related to the pathogenesis of Alzheimer's disease (AD). Development of functional molecules capable of visualizing Aβ1–40 aggregates with nanoscale resolution and even modulating Aβ assembly has attracted great attention recently. In this work, we use monocyanine fluorophore as the lead structure to develop a set of deep red carbazole-based cyanine molecules, which can specifically bind with Aβ1–40 fibril via electrostatic and van der Waals interactions. Spectroscopic and microscopic characterizations demonstrate that one of these fluorophores, (E)-1-(2-(2-methoxyethoxy)ethyl)-4-(2-(9-methyl-9H-carbazol-3-yl)vinyl) quinolinium iodide (me-slg) can bind to Aβ1–40 aggregates with strong fluorescence enhancement. The photophysical properties of me-slg at the single-molecule level, including low "on/off" duty cycle, high photon output, and sufficient switching cycles, enable real-time nanoscopic imaging of Aβ1–40 aggregates. Morphology-dependent toxic effect of Aβ1–40 aggregates toward PC12 cells is unveiled from in situ nanoscopic fluorescence imaging. In addition, me-slg displays a strong inhibitory effect on Aβ1–40 fibrillation in a low inhibitor-protein ratio (e.g., I:P = 0.2). A noticeably reduced cytotoxic effect of Aβ1–40 after the addition of me-slg is also confirmed. These results afford promising applications in the design of a nanoscopic imaging probe for amyloid fibril as well as the development of inhibitors to modulate the fibrillation process.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c03400?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c03400</a>. Chemicals and materials, synthesis of carbazole-based cyanine fluorophores, characterizations of me-slg, slg, and slm, preparation of β-amyloid aggregates, PI and Hoechst 33342 co-staining assay, cytotoxicity assay, supporting figures and references described in the manuscript (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c03400/suppl_file/nn0c03400_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly include two aspects: 1. **Visualization of β - amyloid (Aβ) aggregation in Alzheimer's disease (AD)**: - Alzheimer's disease is a common neurodegenerative disease, and one of its characteristics is the deposition and aggregation of β - amyloid (Aβ). These aggregates can form fibrillar structures (fibrils) and further develop into plaques, affecting the normal function of nerve cells and even leading to cell apoptosis. - Due to the limitation of the diffraction limit, the existing optical microscope techniques are unable to observe the morphological changes of Aβ aggregates in real - time at the nanoscale. Therefore, it is of great significance to develop methods for high - resolution imaging of Aβ aggregates at the nanoscale. 2. **Inhibiting Aβ aggregation to reduce cytotoxicity**: - Recent studies have shown that Aβ oligomers or short fibrils (rather than long fibrils) may be the most cytotoxic forms. Therefore, the development of small molecules that can effectively inhibit Aβ aggregation is of great significance for understanding the pathogenic mechanism of Aβ and developing potential treatment strategies. - By designing and synthesizing a series of deep - red fluorescent molecules (especially me - slg), the paper not only achieved high - resolution imaging of Aβ aggregates but also demonstrated the strong inhibitory effect of these molecules on Aβ fibrillogenesis at a low inhibitor - protein ratio (such as I:P = 0.2), thereby significantly reducing the cytotoxicity of Aβ. ### Specific problems and their solutions - **Problem 1: How to achieve high - resolution imaging of Aβ aggregates?** - **Solution**: The researchers designed and synthesized carbazole - based cyanofluorescent molecules (me - slg). These molecules can specifically bind to Aβ1 - 40 fibrils through electrostatic and van der Waals forces and exhibit strong fluorescence enhancement after binding. Especially at the single - molecule level, me - slg shows a low "on/off" duty cycle, high photon output, and sufficient switching cycles, making it suitable for super - resolution imaging. Through single - molecule localization microscopy (SMLM) technology, the researchers successfully performed real - time imaging of Aβ1 - 40 aggregates at the nanoscale with a resolution improvement of more than ten times. - **Problem 2: How to inhibit Aβ aggregation to reduce cytotoxicity?** - **Solution**: me - slg can not only bind to Aβ1 - 40 aggregates but also effectively inhibit the fibrillogenesis process of Aβ1 - 40. The experimental results show that at a low inhibitor - protein ratio (I:P = 0.2), me - slg can significantly slow down the fibrillogenesis rate of Aβ1 - 40 and significantly reduce its cytotoxicity to PC12 cells. This provides an important reference for the development of new Aβ aggregation inhibitors. ### Summary By designing and synthesizing deep - red fluorescent molecules (me - slg) with specific recognition ability and self - blinking effect, this paper successfully solves the problems of real - time imaging of Aβ aggregates at the nanoscale and inhibiting Aβ aggregation to reduce cytotoxicity. These research results not only help to deeply understand the pathogenic mechanism of Aβ but also provide new ideas for the development of treatment strategies for Alzheimer's disease.

Deep Red Blinking Fluorophore for Nanoscopic Imaging and Inhibition of β-Amyloid Peptide Fibrillation

A Novel Viscosity Sensitive Hemicyanine Fluorescent Dye for Real-Time Imaging of Amyloid-Β Aggregation

Benzothiazolium Derivative-Capped Silica Nanocomposites for β-Amyloid Imaging In Vivo

N-methylbenzothiazolium based theranostics as fluorescence imaging and photo-oxidation agents for Amyloid-β

Rational design of a high-affinity fluorescent probe for visualizing monitoring the amyloid β clearance effect of anti-Alzheimer's disease drug candidates

An AIE-active Theranostic Probe for Light-Up Detection of Aβ Aggregates and Protection of Neuronal Cells.

A Solvatochromic Near Infrared Fluorophore Sensitive to the Full Amyloid Beta Aggregation Pathway

Preparation of near-infrared AIEgen-active fluorescent probes for mapping amyloid-β plaques in brain tissues and living mice

Development of BODIPY-based fluorescent probes for imaging Aβ aggregates and lipid droplet viscosity

Novel pyrrolidine-alkylamino-substituted dicyanoisophorone derivatives as near-infrared fluorescence probe for imaging β-amyloid in vitro and in vivo

Rational Design of Quinoxalinone-Based Red-Emitting Probes for High-Affinity and Long-Term Visualizing Amyloid-β In Vivo

Molecular engineering of a theranostic molecule that detects Aβ plaques, inhibits Iowa and Dutch mutation Aβ self-aggregation and promotes lysosomal biogenesis for Alzheimer's disease

Dual-Emission GFP Chromophore-Based Derivative for Imaging and Discriminating Aβ Oligomers and Aggregates

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Rational design synthesis and evaluation of a novel near-infrared fluorescent probe for selective imaging of amyloid-β aggregates in Alzheimer's disease

An AIE-Active NIR Fluorescent Probe with Good Water Solubility for the Detection of Aβ1–42 Aggregates in Alzheimer’s Disease

Design and synthesis of hemicyanine-based NIRF probe for detecting Aβ aggregates in Alzheimer's disease

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Mitochondria Targeted De Novo Designed Aggregation-Induced Emission Probe for Selective Detection of Neurotoxic Amyloid‐β Aggregates

Rational design of hydroxytricyanopyrrole-based probes with high affinity and rapid visualization for amyloid-β aggregates in vitro and in vivo

Curved carbon photo-oxygenation catalysts for the suppression and nanoscopic imaging of β-amyloid peptides fibrillation